Apyx Medical (APYX) EBIT Margin (2011 - 2026)
Apyx Medical's (APYX) quarterly EBIT Margin came in at 13.01% in Q2 2026, up 962.0% on a YoY basis from 1.22% in Q2 2025, and down 78.34% quarter-over-quarter from 7.29% in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) EBIT Margin (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported EBIT Margin for 16 consecutive years, with 13.01% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin rose 962.0% year-over-year to 13.01%; the trailing twelve-month figure through Jun 2026 stood at 6.06% (up 2041.0% YoY), and the FY2025 full-year result was 12.2%, up 2698.0% from the prior year.
- EBIT Margin retreated to 13.01% in Q2 2026 per APYX's latest filing, from 7.29% in the prior quarter.
- Across five years, EBIT Margin topped out at 0.06% in Q4 2025 and bottomed at 64.57% in Q1 2024.
- Historically, EBIT Margin has averaged 33.0% across 5 years, with a median of 35.54% in 2023.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin plunged 3699 bps in 2022, then jumped 4896 bps in 2023.
- Over 5 years, EBIT Margin stood at 47.05% in 2022, then increased by 16 bps to 39.39% in 2023, then soared by 46 bps to 21.43% in 2024, then surged by 100 bps to 0.06% in 2025, then sank by 22762 bps to 13.01% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 13.01%, 7.29%, and 0.06% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Apyx Medical | 125.85 Mn | 98.23 Mn | 8.87 Mn | -13.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.01% |
| Mar 31, 2026 | -7.29% |
| Dec 31, 2025 | 0.06% |
| Sep 30, 2025 | -6.46% |
| Jun 30, 2025 | -22.63% |
| Mar 31, 2025 | -32.35% |
| Dec 31, 2024 | -21.43% |
| Sep 30, 2024 | -31.64% |
| Jun 30, 2024 | -45.66% |
| Mar 31, 2024 | -64.57% |
| Dec 31, 2023 | -39.39% |
| Sep 30, 2023 | -38.72% |
| Jun 30, 2023 | -9.10% |
| Mar 31, 2023 | -46.21% |
| Dec 31, 2022 | -47.05% |
| Sep 30, 2022 | -63.44% |
| Jun 30, 2022 | -58.06% |
| Mar 31, 2022 | -46.99% |
| Dec 31, 2021 | -10.06% |
| Sep 30, 2021 | -33.54% |